Related Experiment Video
Updated: Aug 14, 2026

Real-Time Polymerase Chain Reaction-Based Detection and Quantification of Hepatitis B Virus DNA
Published on: December 15, 2023
[Factors influencing clinical course of viral hepatitis]
1Klinicki odjel za gastroenterologiju, Klinika za unutrasnje bolesti, Klinicka bolnica Split, Split, Hrvatska. stjepan.mise@st.htnet.hr
Insights
Hepatitis B and C present global health challenges with complex courses and limited treatments. Understanding risk factors for cirrhosis and liver cancer in Hepatitis B, and cirrhosis in Hepatitis C, is crucial for patient outcomes.
Area of Science:
- Hepatology and Viral Gastroenterology
- Infectious Diseases Epidemiology
Context:
- Hepatitis B and C infections exhibit high global prevalence and intricate clinical trajectories.
- Current antiviral therapies demonstrate limited efficacy for both Hepatitis B and C.
- Hepatitis B's course is significantly influenced by local factors and vertical transmission, often leading to chronic infection.
Purpose:
- To elucidate the multifaceted factors influencing the prevalence and progression of Hepatitis B and C.
- To identify key predictors for cirrhosis and hepatocellular carcinoma (HCC) in Hepatitis B patients.
- To determine risk factors for cirrhosis in Hepatitis C patients and factors affecting treatment efficacy.
Summary:
- Hepatitis B cirrhosis risk factors include older age, persistent viremia, alcohol, and coinfections (HCV, HDV, HIV). HCC predictors in cirrhotic patients involve age, male sex, alcohol, aflatoxin, coinfections, and inflammation.
- Hepatitis C carries a lower cirrhosis risk, with factors like older age at infection, alcohol abuse, and HBV/HIV coinfection being significant.
- Obesity negatively impacts Hepatitis C treatment effectiveness, while survival in Hepatitis B cirrhotic patients depends on age, albumin, platelets, and splenomegaly.
Impact:
- Informing targeted prevention and management strategies for Hepatitis B and C globally.
- Improving prognostic accuracy for cirrhosis and HCC in Hepatitis B patients.
- Guiding clinical decisions for Hepatitis C treatment and risk mitigation in coinfected individuals.
Abstract:
Hepatitis B and C are diseases characterized by a high global prevalence, complex clinical course and limited efficacy of currently available antiviral therapy. Hepatitis B: local factors have a significant influence not only on the disease prevalence but also on the disease course. Vertical transmission of the infection in the areas of high prevalence results in perinatal infection, which universaly leads to the development of chronic disease. Factors associated with an increased risk of cirrhosis are older age, persistent viremia, coinfection with HCV, HDV and HIV, and consumption of alcohol, while the role of viral genotype is uncertain. Predictors of HCC development in cirrhotic liver are older age, male sex, alcohol abuse, exposure to aflatoxin, coinfection with HCV and HDV, continuously active inflammation, and potentially viral genotype. Survival predictors in cirrhotic patients are age, serum albumin, platelet count and splenomegaly as a reflection of portal hypertension. Hepatitis C: the risk of cirrhosis is low. Risk factors for cirrhosis are infection in older age, alcohol abuse, and coinfection with HBV and HIV. Obesity has negative impact on treatment efficacy.
Related Concept Videos
Hepatitis
Viral Hepatitis I: Introduction
Hepatic Drug Excretion: Influencing Factors
Factors Affecting Illness
For instance, risk factors are connected to illness, disability,...
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin create...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
